# Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature

> **NCT00198380** · PHASE2 · COMPLETED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 90 (actual)

## Conditions studied

- Pneumonic-type Adenocarcinoma (P-ADC)
- Lung Adenocarcinoma With Bronchiolo-alveolar Feature

## Interventions

- **DRUG:** Gefitinib

## Key facts

- **NCT ID:** NCT00198380
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-04
- **Primary completion:** 2008-12
- **Final completion:** 2009-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2024-03-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00198380

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00198380, "Treatment of Lung Adenocarcinoma With Bronchioloalveolar Feature". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT00198380. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*